New Delhi: Two Covid-19 vaccines —Covaxin by Bharat Biotech and Covishield by the Serum Institute of India — have received "conditional market authorisation" from India's drug regulator, Union Health Ministry announced on Thursday.
The approval was granted under the New Drugs and Clinical Trials Rules, 2019 after recommendations from the Subject Expert Committee (SEC) under the drug regulatory authority to upgrade the status for the vaccines from restricted use in emergency situations to grant of new drug permission with conditions in the adult population on Jan. 19, the Ministry informed.
